Literature DB >> 11687952

Blocking Chk1 expression induces apoptosis and abrogates the G2 checkpoint mechanism.

Y Luo1, S K Rockow-Magnone, P E Kroeger, L Frost, Z Chen, E K Han, S C Ng, R L Simmer, V L Giranda.   

Abstract

Checkpoint kinase 1 (Chk1) is a checkpoint gene that is activated after DNA damage. It phosphorylates and inactivates the Cdc2 activating phosphatase Cdc25C. This in turn inactivates Cdc2, which leads to G2/M arrest. We report that blocking Chk1 expression by antisense or ribozymes in mammalian cells induces apoptosis and interferes with the G2/M arrest induced by adriamycin. The Chk1 inhibitor UCN-01 also blocks the G2 arrest after DNA damage and renders cells more susceptible to adriamycin. These results indicate that Chk1 is an essential gene for the checkpoint mechanism during normal cell proliferation as well as in the DNA damage response.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11687952      PMCID: PMC1506209          DOI: 10.1038/sj.neo.7900175

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  44 in total

1.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein.

Authors:  A Lopez-Girona; B Furnari; O Mondesert; P Russell
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

2.  Role of the cdc25C phosphatase in G2 arrest induced by nitrogen mustard.

Authors:  P M O'Connor; D K Ferris; I Hoffmann; J Jackman; G Draetta; K W Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

3.  C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding.

Authors:  C Y Peng; P R Graves; S Ogg; R S Thoma; M J Byrnes; Z Wu; M T Stephenson; H Piwnica-Worms
Journal:  Cell Growth Differ       Date:  1998-03

4.  Staurosporine blocks cell progression through G1 between the cyclin D and cyclin E restriction points.

Authors:  J Gong; F Traganos; Z Darzynkiewicz
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

5.  A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.

Authors:  A Blasina; I V de Weyer; M C Laus; W H Luyten; A E Parker; C H McGowan
Journal:  Curr Biol       Date:  1999-01-14       Impact factor: 10.834

6.  Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells.

Authors:  K J Russell; L W Wiens; G W Demers; D A Galloway; S E Plon; M Groudine
Journal:  Cancer Res       Date:  1995-04-15       Impact factor: 12.701

7.  Effect of UCN-01, a selective inhibitor of protein kinase C, on the cell-cycle distribution of human epidermoid carcinoma, A431 cells.

Authors:  S Akinaga; K Nomura; K Gomi; M Okabe
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

8.  Chk1 complements the G2/M checkpoint defect and radiosensitivity of ataxia-telangiectasia cells.

Authors:  P Chen; M Gatei; M J O'Connell; K K Khanna; S J Bugg; A Hogg; S P Scott; K Hobson; M F Lavin
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

9.  p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression.

Authors:  S el Rouby; A Thomas; D Costin; C R Rosenberg; M Potmesil; R Silber; E W Newcomb
Journal:  Blood       Date:  1993-12-01       Impact factor: 22.113

10.  p53 mutations increase resistance to ionizing radiation.

Authors:  J M Lee; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

View more
  13 in total

1.  Regulation of microtubule, apoptosis, and cell cycle-related genes by taxotere in prostate cancer cells analyzed by microarray.

Authors:  Yiwei Li; Xingli Li; Maha Hussain; Fazlul H Sarkar
Journal:  Neoplasia       Date:  2004 Mar-Apr       Impact factor: 5.715

Review 2.  Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.

Authors:  David R Raleigh; Daphne A Haas-Kogan
Journal:  Future Oncol       Date:  2013-02       Impact factor: 3.404

Review 3.  Exosomes-mediate microRNAs transfer in breast cancer chemoresistance regulation.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro; Luis Otávio Sarian; Manoela Marques Ortega; Sophie Françoise Derchain
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

4.  Identification of potential therapeutic targets in malignant mesothelioma using cell-cycle gene expression analysis.

Authors:  Solange Romagnoli; Ester Fasoli; Valentina Vaira; Monica Falleni; Caterina Pellegrini; Anna Catania; Massimo Roncalli; Antonio Marchetti; Luigi Santambrogio; Guido Coggi; Silvano Bosari
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

5.  Negative regulation of mitotic promoting factor by the checkpoint kinase chk1 in simian virus 40 lytic infection.

Authors:  Eiji Okubo; John M Lehman; Thomas D Friedrich
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 6.  Platinum Complexes in Colorectal Cancer and Other Solid Tumors.

Authors:  Beate Köberle; Sarah Schoch
Journal:  Cancers (Basel)       Date:  2021-04-25       Impact factor: 6.639

7.  Isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/m cell cycle arrest and apoptosis.

Authors:  Hefen Sun; Helei Hou; Ping Lu; Lixing Zhang; Fangyu Zhao; Chao Ge; Tingpu Wang; Ming Yao; Jinjun Li
Journal:  PLoS One       Date:  2012-05-18       Impact factor: 3.240

8.  CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia.

Authors:  Husheng Ding; Nicole D Vincelette; Cordelia D McGehee; Mira A Kohorst; Brian D Koh; Annapoorna Venkatachalam; X Wei Meng; Paula A Schneider; Karen S Flatten; Kevin L Peterson; Cristina Correia; Sun-Hee Lee; Mrinal Patnaik; Jonathan A Webster; Gabriel Ghiaur; B Douglas Smith; Judith E Karp; Keith W Pratz; Hu Li; Larry M Karnitz; Scott H Kaufmann
Journal:  Cancer Res       Date:  2021-01-07       Impact factor: 13.312

9.  Enhancement of hypoxia-activated prodrug TH-302 anti-tumor activity by Chk1 inhibition.

Authors:  Fanying Meng; Deepthi Bhupathi; Jessica D Sun; Qian Liu; Dharmendra Ahluwalia; Yan Wang; Mark D Matteucci; Charles P Hart
Journal:  BMC Cancer       Date:  2015-05-21       Impact factor: 4.430

10.  Roles of ATM and ATR-mediated DNA damage responses during lytic BK polyomavirus infection.

Authors:  Mengxi Jiang; Linbo Zhao; Monica Gamez; Michael J Imperiale
Journal:  PLoS Pathog       Date:  2012-08-30       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.